Found 16 matching trials
Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma PHASE2 Background:
The mainstay of therapy for newly diagnosed multiple myeloma p...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant PHASE2 This study will enroll myeloma subjects undergoing autotransplantation. The...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma PHASE2 The purpose of this study was to determine if an idiotype vaccine, made fro...
Show More Location
Scripps Stevens Cancer Center
Learn More & Join Trial
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma PHASE1 Patients with stage-I multiple myeloma are treated with a vaccine made from...
Show More Location
University Hospital Dresden
Learn More & Join Trial
Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma PHASE2 The treatment being investigated is a patient- and tumor-specific therapy k...
Show More Location
Keck School of Medicine of University Southern California
Learn More & Join Trial
Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy NA This is a compassionate use protocol for participants who failed induction ...
Show More Location
Unversity of Nebraska Medical Center
Learn More & Join Trial
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines PHASE1 The idiotype of the immunoglobulin on a given B cell malignancy (Id) can se...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma PHASE2 RATIONALE: Vaccines made from a person's cancer proteins may help the body ...
Show More Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Learn More & Join Trial
Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma PHASE2 The purpose of this study is to evaluate the ability of patients treated wi...
Show More Location
University of California, San Diego
Learn More & Join Trial
Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant PHASE2 The goal of this clinical research study is to learn if vaccinating a donor...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial